Effectiveness of sacubitril–valsartan in cancer patients with heart failure

Effectiveness of sacubitril–valsartan in cancer patients with heart failure

Abstract Aims Current guidelines recommend sacubitril/valsartan for patients with heart failure and reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy and safety in cancer therapy‐related cardiac dysfunction (CTRCD). Our aim was to analyse the potential...

Full description

Bibliographic Details
Main Authors: Ana Martín‐Garcia, Teresa López‐Fernández, Cristina Mitroi, Marinela Chaparro‐Muñoz, Pedro Moliner, Agustin C. Martin‐Garcia, Amparo Martinez‐Monzonis, Antonio Castro, Jose L. Lopez‐Sendon, Pedro L. Sanchez
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:ESC Heart Failure
Subjects:
Cancer
Cardio‐oncology
Cardiotoxicity
Heart failure
Sacubitril–valsartan
Online Access:https://doi.org/10.1002/ehf2.12627

Internet

https://doi.org/10.1002/ehf2.12627

Similar Items